Anterior segment involvement in Epstein–Barr virus: a review. Issue 5 (11th November 2021)

• Record Type: Journal Article
• Authors: Alba‐Linero, Carmen; Rocha‐de‐Lossada, Carlos; Rachwani‐Anil, Rahul; Sainz‐de‐la‐Maza, Maite; Sena‐Corrales, Gabriel; Romano, Vito; Rodríguez‐Calvo‐de‐Mora, Marina
• Is Part Of: Acta ophthalmologica. Volume 100:Issue 5(2022)
• Page Start: e1052
• Page End: e1060
• Publication Date: 2021-11-11
• Subjects: Epstein–Barr virus -- anterior segment -- ocular surface -- cornea -- anterior uveitis -- viral infection; Ophthalmology -- Periodicals; 617.7005
• DOI: 10.1111/aos.15061
• Languages: English
• ISSNs: 1755-375X

Abstract

Abstract: The aim of this study is to describe the involvement of Epstein–Barr Virus (EBV) in the diseases of the ocular anterior segment. This is a narrative review designed using the PUBMED, SCOPE and Web of Science databases, searching for reported literature on findings in the anterior ocular segment related to EBV between 1990 and 2020. Epstein–Barr Virus (EBV) is implicated in the development of salmon‐coloured conjunctival masses in the context of acute mononucleosis and lymphoproliferative disorders. Moreover, EBV can cause haemorrhagic conjunctivitis and its corneal implications appear as different types of keratitis patterns. The involvement of EBV in the pathogenesis of anterior segment inflammation is not well‐defined. Current evidence regarding anterior segment disease caused by EBV infection has been proved by positive viral detection through polymerase chain reaction test in eyes with lymphoproliferative disorders known to be caused by EBV, as B‐ and NK/T‐cell lymphoid tumours. Antiviral treatment (oral Aciclovir or Valaciclovir) in anterior segment disease caused by EBV remains controversial.